Clinical Trials
- Heart/Cardiovascular
The WARN Study
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
PROTECT H2H – Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Ages18 years and older
- GenderBoth
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Genetics
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)
- Ages84 years and younger
- GenderBoth